Moderna – Instametta

Moderna to Pay Almost $1 Billion to Settle Arbutus Litigation

Moderna Inc. agreed to pay $950 million to settle all litigation worldwide with Arbutus Biopharma Corp. and Genevant Sciences GmbH…

Moderna (MRNA) stock closed higher on Wednesday after the FDA reversed its earlier refusal-to-file decision on the company’s mRNA-1010 seasonal…

The pharmaceutical giant expressed optimism that its new flu shot would be available this year, after approval concerns. Listen to…

The United States Food and Drug Administration (FDA) has refused to review Moderna’s application for approval of a flu vaccine,…

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024.…

Behind the household COVID-19 name, Moderna, is facing a $5 billion patent-infringement lawsuit over vaccine technology. On February 2, 2026,…

By Patrick Wingrove Jan 12 (Reuters) – Moderna said on Monday it expects to report around $1.9 billion in sales…

Moderna is to expand its US manufacturing capabilities with the onshoring of drug product manufacture to its existing Moderna Technology…

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.…

We recently published 10 Stocks Jim Cramer Mentioned As He Talked About “Love Lost” Between Microsoft & OpenAI. Moderna, Inc.…